Skip to main content
. 2018 Jul 27;9(4):377–388. doi: 10.3892/mco.2018.1685

Table VIII.

Univariate analysis considering triple-negative breast cancer patients.

Variables Number of patients Median survival (years) 95% confidence interval P-value
Overall survival
Claudin 4 0.56
  Negative 63 5.0 2.9–7.08
  Positive 114 6.0 2.3–9.6
Claudin 7 0.82
  Negative 87 6.0 3.13–8.87
  Positive 75 16.0 3.0–10.95
Disease-free survival
Claudin 4 0.35
  Negative 57 6.0 2.2–9.8
  Positive 99 15.0 7.3–22.6
Claudin 7 0.79
  Negative 79 15.0 3.23–26.8
  Positive 63 Not achieved Not determined

P-value was determined by the log-rank test.